Focus Reports
World Personalized Medicine Tests for Cancer
This report forecasts total world demand in 2021 for personalized medicine tests for cancer by major world region in US dollars at the manufacturers' level.
Free Sample Report
Request a free sample of this report and our team will email it to you.
Report Overview
World Personalized Medicine Tests for CancerThis report forecasts total world demand in 2021 for personalized medicine tests for cancer by major world region in US dollars at the manufacturers' level. Major world regions include North America, the European Union, and the rest of the world.
To illustrate historical trends world demand (including regional segments) is provided for 2016. A World Overview and Forecasts section provides pertinent topical background, including technologies used, test targets, prroducts on the market, and global demand. A Regional Segmentation and Forecasts section provides an overview of demand by region.
Further analysis includes an Industry Structure section, which surveys the supply base and identifies the leading firms competing to serve global demand. An introductory Highlights section summarizes key findings from this 29-page report, and a Resources section lists contributing sources as well as resources available for further research.
- HIGHLIGHTS
- WORLD OVERVIEW & FORECASTS
- Introduction
- Cancer Treatments
- Cancer Risk Assessment
- Cancer Screening
- Cancer Monitoring
- Technologies Used
- Immunoassays
- Immunohistochemistry
- Flow Cytometry
- In Situ Hybridization
- Nucleic Acid Amplification Technologies
- Analysis of Gene Expression Patterns (Gene Signatures)
- Microarrays
- Sequencing Technologies
- Mass Spectrometry
- Liquid Biopsies
- Information Technology
- Test Targets
- Human Epidermal Growth Factor Receptor 2 (HER2) Overexpression
- Epidermal Growth Factor Receptor
- Kirsten Rat Sarcoma Mutations
- BRAF Mutations
- Uridine Diphosphate-Glucuronyl Transferase 1A1 Genetic Variants
- 5-Fluorouracil Therapy
- Phosphatidylinositol 3-Kinase Gene Mutations
- Kinesin-Like Protein 6 Mutations
- Anaplastic Lymphoma Kinase Mutations
- Products on the Market
- Table | Select Personalized Medicine Testing Products for Cancer
- Demand
- Figure 1 | World Personalized Medicine Tests for Cancer Demand; 2016, 2021
- Table | World Personalized Medicine Tests for Cancer Demand; 2016, 2021
- Introduction
- REGIONAL SEGMENTATION & FORECASTS
- Regional Demand Overview
- Figure 2 | World Personalized Medicine Tests for Cancer Demand by Region; 2016, 2021
- Table | World Personalized Medicine Tests for Cancer Demand by Region; 2016, 2021
- Regional Demand Overview
- INDUSTRY STRUCTURE
- Industry Characteristics
- Abbott Laboratories
- BioMérieux
- Quest Diagnostics
- Roche Holding
- Industry Characteristics
- ABOUT THIS REPORT
- Scope & Method
- Sources
- Industry Codes
- Table | Industry Codes Related to Personalized Medicine Tests for Cancer
- Resources
